Differential Expression of VEGF-Axxx Isoforms Is Critical for Development of Pulmonary Fibrosis
Open Access
- 15 August 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 196 (4) , 479-493
Abstract
Rationale: Fibrosis after lung injury is related to poor outcome, and idiopathic pulmonary fibrosis (IPF) can be regarded as an exemplar. Vascular endothelial growth factor (VEGF)-A has been implicated in this context, but there are conflicting reports as to whether it is a contributory or protective factor. Differential splicing of the VEGF-A gene produces multiple functional isoforms including VEGF-A165a and VEGF-A165b, a member of the inhibitory family. To date there is no clear information on the role of VEGF-A in IPF. Objectives: To establish VEGF-A isoform expression and functional effects in IPF. Methods: We used tissue sections, plasma, and lung fibroblasts from patients with IPF and control subjects. In a bleomycin-induced lung fibrosis model we used wild-type MMTV mice and a triple transgenic mouse SPC-rtTA+/−TetoCre+/−LoxP-VEGF-A+/+ to conditionally induce VEGF-A isoform deletion specifically in the alveolar type II (ATII) cells of adult mice. Measurements and Main Results: IPF and normal lung fibroblasts differentially expressed and responded to VEGF-A165a and VEGF-A165b in terms of proliferation and matrix expression. Increased VEGF-A165b was detected in plasma of progressing patients with IPF. In a mouse model of pulmonary fibrosis, ATII-specific deficiency of VEGF-A or constitutive overexpression of VEGF-A165b inhibited the development of pulmonary fibrosis, as did treatment with intraperitoneal delivery of VEGF-A165b to wild-type mice. Conclusions: These results indicate that changes in the bioavailability of VEGF-A sourced from ATII cells, namely the ratio of VEGF-Axxxa to VEGF-Axxxb, are critical in development of pulmonary fibrosis and may be a paradigm for the regulation of tissue repair.Keywords
This publication has 60 references indexed in Scilit:
- Vascular endothelial growth factor enhances macrophage clearance of apoptotic cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- The rising incidence of idiopathic pulmonary fibrosis in the UKThorax, 2011
- VEGF in the lung: a role for novel isoformsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Vascular endothelial growth factors and vascular permeabilityCardiovascular Research, 2010
- Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosisProceedings of the National Academy of Sciences, 2010
- Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic IsoformsJournal of Biological Chemistry, 2010
- VEGF-A splicing: the key to anti-angiogenic therapeutics?Nature Reviews Cancer, 2008
- VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapyBritish Journal of Cancer, 2008
- Autocrine VEGF Signaling Is Required for Vascular HomeostasisCell, 2007
- Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?Thorax, 2006